AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Playtech PLC

Transaction in Own Shares Mar 7, 2019

5196_rns_2019-03-07_52fef6bb-a04c-4b24-9fb9-a5443ab63cf4.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2125S

Playtech PLC

07 March 2019

7 March 2019

Playtech plc (the "Company")

Update on Transactions in Own Shares

As announced on 21 February 2019, Playtech has entered into an irrevocable non-discretionary buy back programme of up to €40 million with its corporate brokers, Goodbody and UBS, under which shares may be repurchased for cancellation.

Due to administrative errors made by Goodbody, the repurchase transactions of, in aggregate, 1,267,429 ordinary shares previously announced as having been undertaken by Goodbody on 22, 25, 26 and 27 February 2019 have been voided. All subsequent repurchases since 27 February 2019 have proceeded as announced.

As a consequence, the updated number of total ordinary shares in issue and total voting rights in the Company is 316,280,000.  This figure for the total number of voting rights may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance & Transparency Rules.

Ends.

Contact:

Chris McGinnis, Director of Investor Relations and Strategic Analysis

James Newman, Director of Corporate Affairs

Tel: +44 (0) 16 2464 5954

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

POSEADDXESXNEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.